Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Banco Santander SA (SAN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Banco Santander SA — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Banco Santander SA trades at $13.59 (market cap $196.43B). The key difference: Banco Santander SA is far larger — about 23.2× Hinge Health Inc. Class A Common Stock's market cap, and Banco Santander SA pays a 2.16% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Banco Santander SA for 55 Days on average.
| HNGE | SAN | |
|---|---|---|
Market Cap | $8.47B | $196.43B |
Volume | 1,624,526 | 9,190,091 |
Sector | Health | Financials |
52-Week High | $105.14 | $15.05 |
52-Week Low | $31.17 | $9.65 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $8.09B | $360.59B |
Dividend Yield | — | 2.16% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Banco Santander (SAN) trades at $13.55, up 0.52% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong profitability with 26.25% net income margin and 16.07% ROE, though recent earnings show volatility with one beat and two misses in the last four quarters. Recent developments include the completion of Webster Financial acquisition, expanding U.S. presence and diversification.
SAN presents a compelling value case with reasonable P/E of 13.68 and strong analyst support (64% buy ratings), but faces headwinds from declining cash flows and high debt levels. The stock offers income potential with upcoming $0.14 dividend, though investors should monitor the sustainability of recent profit margins amid operational cash flow challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Banco Santander SA
Santander's focus is on retail and commercial banking. Latin America is geographically the largest operation, with Brazil by far the largest. Its continental European business is still mainly Iberian. Santander's U.K. presence is the result of the acquisition of building society Abbey. In the U.S., Santander operates a vehicle finance business and a regional bank focused on the Northeastern states.
Read more on SAN →
